Obesity Clinical Trial
Official title:
Food as Medicine: A Quasi-Randomized Control Trial of Healthy Foods for Chronic Disease Management
Verified date | March 2023 |
Source | Akron General Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to investigate the effect of providing healthy foods and nutrition education on participants' body weight, blood pressure, and average blood sugar level. The healthy food offerings tested in this study will help determine which option is best to improve health outcomes among Cleveland Clinic Akron General patients with chronic conditions. Findings from this study could guide doctors in deciding on appropriate nutrition and dietitian services for Cleveland Clinic patients.
Status | Active, not recruiting |
Enrollment | 70 |
Est. completion date | December 30, 2023 |
Est. primary completion date | December 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adults 18 years of age or older who are patients at Akron General Center for Family Medicine - Have body mass index (BMI) equal to or greater that 30kg/m2 AND - Have at least one of the following diagnoses determined based on patients' problem list in the electronic medical record (EMR) and the international classification of diseases, 10th revision (ICD-10) codes: 1. Pre-type 2 diabetes mellitus 2. Type 2 diabetes mellitus 3. Hypertension - Have NOT participated in nutrition counseling at the University of Akron Nutrition Center within the past 6 months Exclusion Criteria: - Food allergies - Pregnant - No access to internet - Need English language interpretation - Currently participating in a structured weight loss program or using weight loss medications - Any condition that, in the Investigator's judgement, interferes with the ability to adhere to study requirements. |
Country | Name | City | State |
---|---|---|---|
United States | Cleveland Clinic Akron General | Akron | Ohio |
Lead Sponsor | Collaborator |
---|---|
Akron General Medical Center | The Cleveland Clinic, The University of Akron |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in participants' body weight | Percent weight loss | From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline | |
Secondary | Pre-type 2 diabetes mellitus: Change in number of medications | Absolute change in number of medications | From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline | |
Secondary | Pre-type 2 diabetes mellitus: Change in medication dosage | Percent change in medication dosage | From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline | |
Secondary | Pre-type 2 diabetes mellitus: Change in HbA1c | Absolute change in HbA1c | From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline | |
Secondary | Type 2 diabetes mellitus: Change in number of medications | Absolute change in number of medications | From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline | |
Secondary | Type 2 diabetes mellitus: Change in medication dosage | Percent change in medication dosage | From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline | |
Secondary | Type 2 diabetes mellitus: Change in HbA1c | Absolute change in HbA1c | From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline | |
Secondary | Hypertension: Change in number of medications | Absolute change in number of medications | Baseline visit (W1) to 16 week visit | |
Secondary | Hypertension: Change in medication dosage | Percent change in medication dosage | Baseline visit (W1) to 16 week visit | |
Secondary | Receipt of healthy food items: The Hunger Vital Sign scale | Values on the scale are: often true, sometimes true, and never true. A positive response to either or both of the first two values (often true, sometimes true) identifies households as being at risk for food insecurity | Baseline visit (W1) to week 16 visit | |
Secondary | Receipt of healthy food items: Eating at America's Table scale | Each reported frequency is expressed as a daily average ranging from 0 to 5. The estimate of the daily number of Pyramid/MyPyramid servings is calculated as average daily frequency x the number of Pyramid/MyPyramid servings for the portion size, summed across all food groups. A higher score for fruits and vegetables indicates a better outcome. | Baseline visit (W1) to week 16 visit | |
Secondary | Receipt of healthy food items: Patient Health Questionnaire-8 Depression Scale | Eight items, each of which is scored 0 to 3, providing a 0 to 24 severity score. Overall score is the sum of the 8 items. A score of 10 or greater is considered major depression, 20 or more is severe major depression. | Baseline visit (W1) to week 16 visit | |
Secondary | Nutrition Education: Healthy Eating and Weight Self-Efficacy Scale | Values on the scale are: Strongly disagree, disagree, neutral, agree, and strongly agree. Responses of agree and strongly agree indicate a better outcome. | Baseline visit (W1) to 16-week visit | |
Secondary | Nutrition Education: Self-Efficacy for Managing Chronic Diseases Scale | Six items, each of which is scored 0 to 10. Overall score is the mean of the 6 items. A higher score indicates a better outcome. | Baseline visit (W1) to 16-week visit |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |